MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), a clinical-stage biotech company focused on biologic and small molecule discovery and development, announced that the companies have entered into an exclusive license and collaboration agreement to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer.
Pages
- Contact us
- Copyright
- Forward-looking statement
- General PO terms and conditions
- MSD | Home
- Our commitment to accessibility for all
- Purchase order terms and conditions
- Responsible Vulnerability Disclosure Program of MSD
- Sitemap
- Stories
- Supplemental Product Information
- Terms of use
- What we do
- Who we are
- History
- Sustainability
- Environmental sustainability
- Impact investing
- MSD Medical Outreach Program
- Philanthropy
- A closer look: MSD Richard T. Clark Fellowship for Global Health
- Advancing equity in cancer care
- Advancing patient-centered cancer care
- Advancing patient-centered cancer care in resource-limited communities
- Enhancing diabetes care through community outreach and support
- Expanding access to cancer care in Asia
- Global emergency response
- Improving access to high-quality diabetes care
- Improving access to HIV care in sub-Saharan Africa
- Improving health care access
- MSD Foundation
- MSD Richard T. Clark Fellowship for Global Health
- Product donation programs
- Promoting equity in HIV/AIDS care
- Strengthening our communities
- Sustainability resources
- Transparency disclosures
- Leadership
- Culture & values
- Diversity & inclusion
- Policies & positions
- Business development & licensing
- Suppliers
- Research
- Business development and licensing
- COVID-19
- Immunology
- Meet our scientists
- Neuroscience
- Publications
- R&D locations
- Safety Data Sheets
- Scientific capabilities
- Vaccines
- Infectious diseases
- Oncology
- Cardio-metabolic diseases
- Pipeline
- Discovery & development
- Clinical Trials
- Diversity in clinical trials
- Product patents
- Product patents
- Patients
- Media
Archives
Categories
- No categories